|
31754.01.01
|
BAVENCIO C/S.SOL.IN 20MG/ML BTx1 VIAL x 10ML
|
|
600,36 |
667,72 |
757,33 |
Merck Europe B.V.
|
|
24112.01.01
|
CETROTIDE PS.INJ.SOL 0,25MG/VIAL BTx1VIAL+1PF.SYRx1ML SOLVENT SOLVENT
|
|
20,50 |
23,56 |
32,47 |
Merck Europe B.V.
|
|
24112.01.02
|
CETROTIDE PS.INJ.SOL 0,25MG/VIAL BTx7VIALS+7PF.SYR x 1ML SOLVENT 1ML SOLVENT
|
|
133,13 |
153,03 |
184,92 |
Merck Europe B.V.
|
|
26728.02.02
|
ERBITUX SOL.INF 5MG/ML BT x 1 VIAL x 20 ML
|
|
131,41 |
151,05 |
182,53 |
Merck Europe B.V.
|
|
22088.10.01
|
GONAL-F IN.SO.PF.P 300IU/0,48ML (22mcg/0,48ML) PEN BTx1PEN x0,5ML
|
|
62,66 |
72,02 |
91,61 |
Merck Europe B.V.
|
|
22088.12.01
|
GONAL-F IN.SO.PF.P 900IU/1,44ML (66mcg/1,44ML) PEN BTx1 PEN x1,5ML
|
|
187,47 |
208,50 |
247,53 |
Merck Europe B.V.
|
|
22088.04.01
|
GONAL-F PS.INJ.SOL 1050IU/1,75ML(77MCG/1,75ML) VIAL (πολλαπλών δόσεων) BTx1VIAL+1PF.SYR.x 2 ML SOLV. ML SOLV.
|
|
237,97 |
264,67 |
314,22 |
Merck Europe B.V.
|
|
24646.01.04
|
LUVERIS PS.INJ.SOL 75IU/1ML VIAL BTx1VIAL+1VIALx1ML SOLV SOLV
|
|
19,54 |
22,46 |
30,95 |
Merck Europe B.V.
|
|
31735.01.01
|
MAVENCLAD TAB 10MG/TAB BTx1 TAB
|
|
1.349,72 |
1.501,16 |
1.650,90 |
Merck Europe B.V.
|
|
31735.01.02
|
MAVENCLAD TAB 10MG/TAB BTx4 TAB
|
|
5.399,10 |
6.004,91 |
6.492,51 |
Merck Europe B.V.
|
|
31735.01.04
|
MAVENCLAD TAB 10MG/TAB BTx6 TAB
|
|
10.569,01 |
11.754,93 |
12.709,43 |
Merck Europe B.V.
|
|
24730.03.01
|
OVITRELLE IN.SO.PF.P 250mcg/0,5ML PF.PEN BTx1PF.PENx0,5ML+1 βελόνα βελόνα
|
|
20,46 |
23,51 |
32,39 |
Merck Europe B.V.
|
|
24730.02.01
|
OVITRELLE INJ.SOL 250MCG/0,5ML PF.SYR BTx1PF.SYRx0,5MLSOLV
|
|
20,83 |
23,93 |
32,98 |
Merck Europe B.V.
|
|
27922.02.01
|
PERGOVERIS INJ.SOL (300+150)IU/0,48ML (PF.PEN) 1 PF.PEN + 5 βελόνες
|
|
108,13 |
124,30 |
152,84 |
Merck Europe B.V.
|
|
27922.04.01
|
PERGOVERIS INJ.SOL (900+450)IU/1,44ML (PF.PEN) 1 PF.PEN + 14 βελόνες
|
|
318,82 |
354,59 |
413,45 |
Merck Europe B.V.
|
|
27922.01.01
|
PERGOVERIS PS.INJ.SOL (150+75)IU/VIAL BTx1 VIAL + 1 VIAL x 1ML SOLV + 1 VIAL x 1ML SOLV
|
|
57,53 |
66,13 |
84,12 |
Merck Europe B.V.
|
|
23324.08.02
|
REBIF INJ.SOL 12 MU /0,5ML PF.SYR BTx3PF.SYRSx0,5ML
|
|
154,47 |
177,55 |
214,55 |
Merck Europe B.V.
|
|
23324.11.01
|
REBIF INJ.SOL 132MCG (44MCG/0,5ML)/1,5ML CARTRIDGE BTx4 CARTRIDGES
|
|
540,24 |
600,86 |
681,50 |
Merck Europe B.V.
|
|
23324.10.01
|
REBIF INJ.SOL 66MCG (22MCG/0,5ML)/1,5ML CARTRIDGE BTx4 CARTRIDGES
|
|
457,79 |
509,15 |
582,87 |
Merck Europe B.V.
|
|
23324.06.02
|
REBIF INJ.SOL 6MU/0,5ML PF.SYR BTx3PF.SYRx0,5ML
|
|
126,43 |
145,33 |
178,69 |
Merck Europe B.V.
|
